Skip to content

Cardinal Health CAH Free cash flow

Free cash flow at other companies

Cabot Corporation logo
Cabot CorporationCBT
$32M+3,100%
Unifirst logo
UnifirstUNF
$35.22M-6.5%
Warrior Met Coal logo
Warrior Met CoalHCC
-$91.86M-59.5%
Travel + Leisure logo
Travel + LeisureTNL
$19M-81.0%
Bioventus logo
BioventusBVS
$8.36M+141%
Dave, Inc. logo
Dave, Inc.DAVE
$82.01M+81.4%

Other financials

Income statement

See full
Revenue$60.9B+11.0%
Gross profit$2.5B+17.7%
Operating income$509.0M-30.3%
Net income$399.0M-21.1%
EPS (diluted)$1.69-19.5%

Balance sheet

See full
Cash & equivalents$3.9B+18.4%
Total debt$8.9B+16.1%
Total equity-$2.8B+3.9%
Total assets$56.7B+13.7%

Cash flow

See full
Operating cash flow$1.8B-37.6%
CapEx$146.0M+15.9%

Valuation

See full
Market cap$54.98B+41.0%
Enterprise value$59.96B+38.3%
P/E35.4×+10.3×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.2pp
Operating margin0.9%-0.1pp
Net margin0.6%-0.1pp
FCF margin1.7%+0.6pp

Returns & leverage

See full
Return on equity37.4%
Debt / equity4.1×
Current ratio0.9×0.0×

Where this comes from

Calculated from Cardinal Health’s reported figures.

The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cardinal Health's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cardinal Health's free cash flow?
Cardinal Health (CAH) reported free cash flow of $1.68B in Q1 2026.
How has Cardinal Health's free cash flow changed year-over-year?
Cardinal Health's free cash flow decreased by 40.0% year-over-year, from $2.79B to $1.68B.
What is the long-term trend for Cardinal Health's free cash flow?
Over 4 years (2021 to 2025), Cardinal Health's free cash flow has grown at a -2.3% compound annual growth rate (CAGR), from $2.03B to $1.85B.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.